Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs EOIPB in Subcostal Cancer Surgeries
NCT06519708Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by National Cancer Institute. Primary endpoint: Total amount of morphine consumption. Started Jul 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06519708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06519708.